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Background: Exacerbations in severe COPD patients lead to challenges in terms of self-
management. This study is a “real-life” situation aiming to assess whether or not it is possible
for COPD patients with high burden of disease to self-manage acute exacerbations and to reduce
hospital use.
Methods: 100 randomly selected charts of patients followed in a specialised COPD clinic in 2006
and 2009 (patients with higher burden of disease) were reviewed. Data on patients’ character-
istics, COPD severity and exacerbation management were extracted.
Results: Compared to the 2006 cohort, patients from the 2009 cohort had lower (0.85 L), but not
statistically significant different FEV1 (L) than the 2006 cohort (0.98 L) and more exacerbations
(2.6 exacerbations/pt vs 3. 6 exacerbations/pt, pZ 0.03). Despite having a higher burden of dis-
ease, patients in the 2009 cohort as compared to 2006 had more appropriate self-management
behaviours in the event of an exacerbation (60% vs 42%, pZ 0.05) and fewer emergency room
visits and/or hospital admissions (39% vs 57%, pZ 0.02). Thereweremore phone calls to the case
managers (590 vs 382, p < 0.001) and fewer physician office visits (167 vs 179, pZ 0.024).
Conclusions: This study of a real life situation adds to the current body of literature that a more
severe COPD patient population can be taught self-management skills in the event of exacerba-
tions, leading to fewer health care visits and hospital admissions.
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nication with a nurse case manager. Each cohort wasChronic obstructive pulmonary disease (COPD) exacerba-
tions are significant for both patients and the health care
system. They contribute to a faster decline in FEV1 and
worsening of the quality of life1,2 for patients. They also
represent significant costs to the health care system, COPD
being the number one cause of readmission in Canada.3 The
recovery from an exacerbation is also of concern. It has
been shown that up to 14% of exacerbations take more than
35 days for resolution of symptoms and that more than 4%
do not have complete recovery after 91 days.4
It has been shown that there are ways to minimize the
negative impacts of COPD exacerbations. Adherence to an
action plan with a case manager involved can lead to
decreased symptoms recovery time.5 It has also been
demonstrated that hospital admissions can be reduced by up
to 39%, emergency room visits by up to 41% and unscheduled
physician visits bymore than 58%when patients are trained in
an intensive comprehensive self-management program.6e8
However, when a multicenter Veteran Affairs (VA)
cooperative trial attempted to study a similar comprehen-
sive case management program vs. standardized care in
patients hospitalized with advanced COPD in the prior year,
the study was prematurely discontinued due to excessive
mortality in the comprehensive care management group.9
As reported by the investigators, patients in the compre-
hensive care management program were not successful.
They waited almost a week before taking medication. This
was not any sooner than the usual care group. Reason for
excessive mortality is not clear; however close contact with
patients who have a high disease burden may be crucial in
maximizing self-management success.
While these studies were going on, our clinic’s COPD
case managers noted an increased workload and felt that
patients referred had increased disease burden. In this
context, concerns around the efficacy of the self-
management were raised. As the caseload seemed heav-
ier, it was thus assumed by the team that patients had more
severe COPD. Furthermore, there was fear that self-
management represented more work for case managers
and that despite it, health care utilisation secondary to
exacerbations could potentially be rising.
In the present study of a real life situation of patients
monitored in a COPD clinic, we primarily aimed at assessing
whether or not it was possible for patients with high and
increased disease burden to have the ability to properly
self-manage acute exacerbations. This entails patient
adherence to their action plan that triggers prompt recog-
nition of worsening symptoms and timely treatment and
reducing emergency hospital visits and/or admissions. As
secondary objectives, we assessed the need for ongoing
regular contact with a knowledgeable supervising case
manager and for physician visits.
Methods
Study design and selection of patients
This study was a retrospective chart review of two distinct
cohorts of randomly selected patients who were followed ina COPD clinic with self-management program and commu-
separated from 3 years apart based on the assumption that
patients most recently referred to the COPD clinic had a
higher disease burden. We planned to choose fifty patients
from the nurse caseload in each of the 2005e2006 and
2008e2009 patient list. All COPD patients had to be newly
referred and been followed at least once in the COPD clinic
of the Montreal Chest Institute during the subsequent year.
The project received the approval of the Institutional
Research Ethic Board.
Case manager qualifications and tasks
In both 2006 and 2009, the same three case managers were
working at the COPD clinic, thus both cohorts had nurses
that had equivalent skills and knowledge. The case man-
agers were all nurses who were specialised in chronic res-
piratory disease and had at least 5 years experience in
managing complexly ill COPD patients. They were also
competent in motivational interviewing and on knowledge
translation pertaining to the “Living well with COPD” self-
management program. The nurses had access to a respir-
ologist who has chronic respiratory diseases as main inter-
est, in particular COPD. Each patient was assigned to a case
manager and each case manager had a caseload of 70e100
patients. Patients were usually seen in the COPD clinic 2e4
times per year. Case managers were available by phone or
in person in the clinic between 9:00 and 18:00 on weekdays.
After these hours, patients had access to a 24 h hot line and
a community nurse that specialises in COPD. As part of the
action plan strategy, patients were instructed to call the
case manager if new respiratory symptoms developed or if
the prescribed treatment for a COPD exacerbation was
initiated. During visits and/or telephone contacts, the case
manager and/or physician reviewed with the patient the
specific symptoms they experienced when having an exac-
erbation, the action plan that should be implemented and
patients’ adherence when an exacerbation had already
been experienced.
Action plan and COPD exacerbations
Many formats of action plans have been described and used
clinically, but in this study, the term “action plan” refers to
a written document handed to each patient with person-
alised explanations. The written action plan is central to
the program “Living Well with COPD”. It is available on
www.livingwellwithcopd.com (password: COPD) and it
highlights how to take regular medications, to promptly
recognize the worsening of symptoms and to initiate
treatment including the self-administration of antibiotics
and oral corticosteroids. Patients are asked to refer to the
written plan regularly until they are familiar with all in-
halers and other drugs. Both patient cohorts received
training based on the self-management program “Living
well with COPD”.
Exacerbations are often difficult to identify.5,10 As per
the written action plan, an exacerbation is defined as a
change in any of the 3 cardinal respiratory symptoms for
more than 48 h. Symptoms were either an increase or a
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of breath. Patients were instructed to take the prescribed
antibiotics and/or the oral corticosteroids if there was a
persistent change in sputum and/or increased shortness of
breath and not to wait more than 48 h. Patients were also
encouraged to call the case manager as soon as possible to
inform, to allow patients’empowerment over their exac-
erbation and to insure follow up.
Outcome measures
To assess the changes in COPD disease burden from each
cohort, demographics along with FEV1, smoking status,
number of respiratory medications and exacerbations and
comorbidities were collected by reviewing medical charts.
As part of regular practice, nurse and physician visits and
telephone contacts were also systematically recorded in
the medical chart of COPD patients via a standardized form
implemented in 2005. To assess the change in workload
between 2006 (refers to 2005e2006) and 2009 (refers to
2008e2009), each visit or contact, in person or by tele-
phone, was recorded based on the notes in the chart.
. Appropriate self-management behaviours refers to the
ability of the patients to recognise changes in their symp-
toms and act on them, either by calling their case managers
and/or by adjusting their treatment (to initiate antibiotics
and/or oral corticosteroids) for a COPD exacerbation. Ex-
acerbations were systematically recorded in the medical
chart from telephone contact with the case manager. When
patients did not call, the information with respect to an
exacerbation was recorded at their regular visit with the
respirologist. All emergency room visits and hospitalisations
for respiratory reasons within 4 weeks of starting the action
plan were also recorded to evaluate the potential benefit,
i.e., hospital use outcomes post action plan.
Statistical analysis
Analyses were performed with SAS (version 9.1, SAS Insti-
tute; Cary, NC). For the primary and secondary outcomes,
comparisons of the two cohorts were done using unpairedTable 1 Characteristics of the COPD patients in each cohort.a
Cohort 2006 (
Age, years  SD 70.26  9.87
Sex, male 27 (56%)
Smoking history
 Smokers 9 (19%)
 Ex-smokers 39 (81%)
FEV1, liters  SD 0.98  0 0.41
FEV1, % predicted  SD 40%  18%
FEV1/FVC 0.45  0.15
Number of exacerbations 126 (2.6 exac
Therapy with combination (LAAC þ LABA/ICS) 26 (54%)
Pulmonary rehabilitation 38 (79%)
Referral in the community 44 (92%)
SD: Standard deviation; FEV1: Forced expiratory volume in 1 s; FVC:
Long-acting beta-agonist; ICS: Inhaled cortico-steroids.
a 2006 refers to 2005e2006 and 2009 refers to 2008e2009.student t-test (continuous data) and chi-square test (bino-
minal data). We considered p values <0.05 as statistically
significant.
Results
After random selection, 50 chart numbers were identified in
each cohort. Retrieval of charts based on chart number lead
to the exclusion of 2 from the 2006 cohort and 4 from the
2009. These charts were excluded because they could not be
retrieved from the archives at the time of the chart review.
They had been requested elsewhere and no tracking system
existed at that time. From the 2006 and 2009 cohorts 48 and
46 distinct charts were kept for the study.
Characteristics of the COPD patients are presented in
Table 1. Patients from the 2 cohorts were comparable with
respect to sex, age, co-morbid conditions. Patients in the
2009 cohort as compared to those in the 2006 cohort
showed a non statistically significant trend for more severe
airflow obstruction and a statistically significant increase in
the frequency of exacerbations, i.e., a higher burden of
disease, while being more often prescribed a combination
of long acting anticholinergic, long acting beta-agonist and
inhaled corticosteroids.
Table 2 shows that patients in the 2009 cohort as
compared to those in the 2006 cohort have better self-
management behaviours in the event of an exacerbation,
i.e., a call by the patient to the case manager if new respi-
ratory symptoms develop or if the patient initiated the pre-
scribed treatment for a COPD exacerbation, and decreased
emergency department visits and hospital admissions.
Table 3 shows the number of visits and telephone calls
with case managers and physicians in the cohorts from 2006
to 2009. There was an increase in telephone calls with case
managers while for the same period, there was a decrease
in visits to case managers and physicians.
Discussion
This study of a real life situation demonstrated that in se-
vere COPD patients more prone to exacerbations, patientsN Z 48) Cohort 2009 (N Z 46) p-Values
69.74  9.50 0.70
25 (54%) 0.80
6 (13%) 0.50
40 (87%) 0.50
0.85  0.37 0.14
34%  15% 0.17
0.43  0.15
erbations/pt) 167 (3.6 exacerbations/pt) 0.03
37 (80%) 0.07
38 (83%) 0.41
44 (96%) 0.92
Forced vital capacity; LAAC: Long-acting anticholenergic; LABA:
Table 2 Self-management behaviours according to the action plan in the event of an exacerbation and hospital use.a
Cohort 2006 Cohort 2009 p-Value
Number of exacerbations 126 167 0.03
Appropriate self-management behavioursb 54 (42%) 101 (60%) 0.05
Hospital usec 72 (57%) 66 (39%) 0.024
a 2006 refers to 2005e2006 and 2009 refers to 2008e2009.
b Appropriate self-management behaviours are defined as a call by the patient to the case manager if new respiratory symptoms
develop or if the prescribed treatment for a COPD exacerbation was initiated.
c Hospital use is defined as a visit to the emergency room or an admission to the hospital within 4 weeks of initiating an action plan.
1064 J. Bourbeau et al.increased their ability to properly self-manage their acute
exacerbations and reduced emergency hospital visits and/
or admissions.
It has been shown that exacerbations lead to prolonged
symptoms which do not return to pre-exacerbation level.11
Early treatment is necessary to help recovery and avoid
early mortality.12 Our study is the first to show in a clinical
setting that COPD patients with increased disease burden can
successfully develop self-management behaviour. These re-
sults are conflictingwith those of the VA trial.9 As reported by
the investigators, patients in the comprehensive care man-
agement program did not take medication any sooner than
the usual care group. The study care managers who instruc-
ted the cohort had varying professional backgrounds that
included nurses, respiratory therapists, study coordinators
and medical assistants. Their background and skills in man-
aging complex and very ill COPD patients was unclear. A
greater number of patients in the interventional arm had
fatal COPD related events and less urgent ER visits, suggest-
ing less intense treatment received by the comprehensive
caremanagement arm. These data also suggest that in the VA
trial, the comprehensive care management plan failed in its
intent to provide timely care for patients with worsening
symptoms of exacerbations. This shows the importance of
measuring the intended behaviour of self-managing COPD.
It has also been demonstrated that exacerbations and
hospital admissions for a COPD exacerbations lead to
increased mortality and morbidities,11,13,14 hence avoiding
hospitalisation is essential. Our study adds to previous
publications by demonstrating that despite increases in
exacerbations per patient over time, physician office visits
can still be minimized by implementing a case manager run
program. However, in order to be effective and harmless to
patients and to lead to appropriate self-management be-
haviours, the program must include essential componentsTable 3 Visits and telephone calls with the case manager
and the physician.a
Cohort
2006
Cohort
2009
p-Value
Phones calls to the
case manager
382 590 < 0.001
Clinical visits to the
case manager
184 113 < 0.001
Clinical visits to the
physician
179 167 0.02
a 2006 refers to 2005e2006 and 2009 refers to 2008e2009.such as easy access, timely interaction and increased
telephone communications with a highly skilled case man-
ager. In our study, the same training had been given to both
groups, so the increase in phone calls does reflect proper
integration of self-management skills despite the severity
of the disease.
The increase in phone communications in the context of
an exacerbation has some clinical importance. This obser-
vation reinforces the previously emphasized need to put
action plans in place in the setting of appropriate teaching
and coaching.7,15 An increase in phone calls could have
created new opportunities for patient empowerment. It has
been demonstrated that in chronic disease management,
patients need to be informed and guided in order to gain
empowerement.16,17 Case managers provide the teaching
necessary in COPD to allow empowerment and this study
shows that it is a resource that severe COPD patients use to
take proper action in the event of an exacerbation and to
decrease emergency visits and hospital admissions.
This study highlights the feasibility of implementing a
self-management program in a population of COPD patients
with an increased and high burden of disease. Furthermore,
the study reports results from a real life situation
enhancing the applicability of such practice. The study’s
main focus was on measuring intermediate outcomes, such
as intended behaviour change and the process of self-
management, instead of only measuring ultimate out-
comes, such as health service use. This is an essential
attribute of successful self-management programs. Finally,
this study touches on and helps understand why some
programs fail while others work.
Certain limitations to this study should be discussed. The
success of this program in an integrated approach of care
took place in a specialized COPD clinic. It may not be
possible to generalize these results to another practice
setting. This was not a randomized clinical trial. However,
we did not intend to compare patients with similar disease
severity. Our objective was to see if collaborative self-
management could be successful and harmless over time
when COPD patients had increased disease severity. A
clinical trial with data collected prospectively instead of a
chart review would have allowed for a more accurate
recording of exacerbations and of the self-management
behaviours to which they are associated. Another limitation
of the study is related to the fact that it often takes more
than one exacerbation before patients can manage suc-
cessfully. Adherence to self-management instructions takes
time and in the present study, we don’t know how long
patients had to be followed to manage their exacerbations
properly. Furthermore, adherence may not only depend on
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factors, such as exacerbation severity and time to next
exacerbation. None of the patients’ charts documented a
death occurring during the year that of it’s review..
This study adds to the current body of literature
demonstrating that a more severe COPD patient population
can implement self-management skills (i.e. they can apply
the principles being taught) in the event of exacerbations
and decrease health care visits and hospital admissions. In
order for a self-management program to be successful and
harmless to patients, this study highlights the necessity for
detailed, easily accessible, and frequent interactive
communication with highly skilled and experienced case-
manager. However, this can only happen in an integrate
system of care well adapted and responsive to patient
needs. Future studies would be necessary to provide com-
plementary information on patients’ decision making and
the need for certain patients to have decisions taken by the
health care professional.
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